KBRA releases its 2026 European project finance and infrastructure (PF&I) Sector Outlook, examining themes that will likely take centre stage in 2026 as well as developments and ratings trends from ...
Pharmaceutical drugs developed by two local companies received approvals in the European Union last month. On Dec. 12, Culver ...
Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both ...
Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from ...
OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or the “Company”), the world leader in listeria-based cancer ...
France’s Ministry of the Armed Forces has taken a significant step to deepen its use of AI by awarding a framework agreement ...
Ocugen (OCGN) rated Buy as OCU410ST Stargardt trial advances; FDA/EMA alignment speeds path to approval. Read here for more ...
ExchangeWire’s 2026 line-up brings the ATS experience to four global hubs, each with its own distinct energy and industry ...
Belfast News Letter on MSN
Brussels changes to over-the-counter medicines rules could push NHS in NI 'to breaking point'
EU rules affecting the sale of common treatments sold in pharmacies risk placing “an unmanageable burden” on Northern Ireland ...
Novel immunotherapy combination regimen brings together two complementary therapies to improve outcomes for people living with multiple myeloma as early as second line1 ...
After an eventful 2025, the next year holds further regulatory changes and a growing disclosure landscape, as companies quiet ...
The Digital Networks Act was supposed to make Big Tech pay. But instead of strict regulation, Netflix, Google, and Meta are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback